Previously published data on the proportion of AML patients expressing B7-H3 vary from 27%, over 44.8%, to up to 60%, with a 2- to 3-fold higher expression in AML compared to healthy samples [16,17,31,33]. Here, CD276 is linked to acute myeloid leukemia.